Tergooi

Hilversum 1213 XZ

1 studies enrolling now · 2 studies all time

What they study most

Coronary Heart Disease (CHD), Metastatic Castration-resistant Prostate Neoplasms

Studies at this site

• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke — Completed